Adaptive Designs in Clinical Drug Development

4-5 February 2009, Copthorne Tara Hotel, London, UK

As adaptive designs begin to move from theoretical discussion to practical implementation, SMi’s conference will provide a panel of top speakers whose knowledge and experience will give you the edge in your clinical research. Implementing Bayesian statistical models will impact on every part of your drug development, so it will be vital to understand the implications of this change – from the move towards a “learn and confirm” paradigm and the increasing necessity of using EDC and similar technologies, to the changing regulatory environment and the impact on supplies and randomisation in the trials themselves.
More info >>

Novozymes Biopolymer Wins Gold Innovation Award for

Novozymes Biopolymer announced winning the Gold Innovation Award at CPhI worldwide conference in Frankfurt, Germany, for its novel form of hyaluronic acid (HA) HyaCare®. The CPhI Innovation Award is established as the showcase for exceptional work in developing research and technology, setting the standards for the pharmaceutical manufacturing industry. The judging panel took into account a number of factors including effective development of the technology and its key benefits to the pharmaceutical industry.
More info >>